China News Service, Shanghai, February 21 (Reporter Zuo Yukun) "Medtronic has always been optimistic about the Chinese market, and firmly believes that China will become the world's largest medical and health market in the future."

  On February 20, under the guidance of the Network Communication Bureau of the Central Cyberspace Administration of China, the online theme promotion media group of "New Era, New Opportunities - Multinational Enterprises in China" sponsored by the Shanghai Municipal Cyberspace Administration and China News Network entered the Medtronic Shanghai Innovation Center. Medtronic Global Senior Vice President and Greater China President Gu Yushao made the above statement.

Gu Yushao, Global Senior Vice President and President of Greater China, Medtronic.

Photo by China News Agency reporter Zhou Sunyu

  In Gu Yushao's view, the medical industry is an innovation-driven industry, especially the medical device industry.

"Whether it is the trend of miniaturization or miniaturization, or innovations in various industries such as AI, VR, and robotics, they can finally be embodied in the medical device industry, so we have always believed that the medical device industry is a sunrise industry."

  Gu Yushao also mentioned that the big difference between the pharmaceutical industry and the medical device industry is that if a good product wants to become a good therapy and truly serve patients, it needs training for medical staff.

Especially high-value consumables and plant-based consumables require medical staff to master therapy and apply it to patients.

  China is the only single market in the world where Medtronic has two innovation centers.

It is understood that the two innovation centers located in Shanghai and Chengdu can train about 15,000 medical professionals each year.

  "Medtronic has always firmly believed that the future of medical technology lies in China, and China's medical and health market will definitely become the largest in the world." Gu Yushao said, so Medtronic hopes that the Chinese market will not only be a production base, but also become the most important source of innovation one day One of them, and this is why we established the Innovation Center in the first place.

  It is reported that Medtronic China R&D Center has more than 300 R&D and management talents, and 50 innovative products were born, 33 of which were successfully launched, and 22 were exported overseas.

The staff displayed the ordinary pacemaker and Medtronic's "world's smallest" pacemaker.

Photo by China News Agency reporter Zhou Sunyu

  In October 2021, Medtronic also signed an investment agreement with the Lingang New Area, becoming the first Fortune 500 multinational medical company to invest in Lingang.

The medical technology industry base project was officially launched in November 2022. "In less than a year from the signing to the start, we have witnessed the 'Lingang Speed' and the 'China Speed'."

  Gu Yushao mentioned that during the past 30 years of development in China, Medtronic has deeply felt the continuous improvement of the business environment.

For example, in order to speed up the launch of innovative products, the government will communicate with enterprises on very specific issues.

"Especially this year, many policies and actions of the government give us confidence in this year and beyond."

  Gu Yushao also mentioned that Medtronic is already the "veteran of the five dynasties" of the Shanghai International Import Expo. Each time the CIIE brings 60-70 globally innovative technologies and treatments, many of them have become "net celebrity" products.

This year, we will continue to participate in the exhibition and bring the latest products to the Chinese market.

  "A series of investment initiatives and diversified local cooperation represent Medtronic's long-term commitment and confidence in the Chinese market." Gu Yushao said that in the future, he will continue to focus on the local long-term development model, continue to consolidate the layout of the local value chain, and help build a local medical ecosystem. , to serve Chinese doctors and patients with stronger local capabilities.

(over)